Literature DB >> 7616996

Time to hit HIV, early and hard.

D D Ho.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7616996     DOI： 10.1056/NEJM199508173330710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  81 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  [Highly active antiretroviral therapy of HIV patients. ART Cohort Collaboration].

Authors:  A Schmid; H H Hirsch
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 3.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 4.  Update in HIV medicine for the generalist.

Authors:  Amina A Chaudhry; Gail Berkenblit; Allen L Gifford; Joseph Cofrancesco; James Sosman; Lynn E Sullivan
Journal:  J Gen Intern Med       Date:  2010-12-08       Impact factor: 5.128

Review 5.  When to start antiretroviral therapy.

Authors:  Cunlin Wang; Saba W Masho; Daniel E Nixon
Journal:  Curr HIV/AIDS Rep       Date:  2006-07       Impact factor: 5.071

6.  Research results have expiration dates: ensuring timely systematic reviews.

Authors:  Julie Barroso; Margarete Sandelowski; Corrine I Voils
Journal:  J Eval Clin Pract       Date:  2006-08       Impact factor: 2.431

Review 7.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?

Authors:  Lionel Piroth; Christine Binquet; Marielle Buisson; Evelyne Kohli; Michel Duong; Michèle Grappin; Michal Abrahamowicz; Catherine Quantin; Henri Portier; Pascal Chavanet
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 9.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

Review 10.  Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group.

Authors:  A R Rachlis; D P Zarowny
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.